Sep 25, 2019 / 08:30PM GMT
Operator
Ladies and gentlemen, thank you for standing by, and welcome to Enanta Pharmaceuticals Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded.
(Operator Instructions) I would now like to hand the conference over to your speaker today, Ms. Carol Miceli, Director of Investor Relations. Please go ahead.
Carol Miceli - Enanta Pharmaceuticals, Inc. - Director of IR
Thank you, Rob, and thanks for joining us. The news release announcing the results of our Phase IIa ARGON-1 study with EDP-305 in NASH patients was issued this afternoon and can be found on the Investors section of our website. Today's conference call is being webcast live with slides. A copy of the slides being presented today will be posted on the Events and Presentations section of our website following the conclusion of the call and webcast.
Participating on the call today is Dr. Jay Luly, President and CEO; and Dr. Nathalie Adda, Senior Vice President and our Chief Medical Officer.
Dr. Adda will present top line results, and
Enanta Pharmaceuticals Inc Call to Discuss ARGON-1 Data Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot